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Abstract
Background: Patterns of symptom clustering in midlife women may suggest common underlying mechanisms or
may identify women at risk of adverse health outcomes or, conversely, likely to experience healthy aging. This
paper assesses symptom clustering in the Study of Women’s Health Across the Nation (SWAN) longitudinally by
stage of reproductive aging and estimates the probability of women experiencing specific symptom clusters. We also
evaluate factors that influence the likelihood of specific symptom clusters and assess whether symptom clustering is
associated with women’s self-reported health status.
Methods: This analysis includes 3289 participants in the multiethnic SWAN cohort who provided information
on 58 symptoms reflecting a broad range of physical, psychological and menopausal symptoms at baseline and
7 follow-up visits over 16 years. We conducted latent transition analyses to assess symptom clustering and to
model symptomatology across the menopausal transition (pre, early peri-, late peri- and post-menopausal). Joint
multinomial logistic regression models were used to identify demographic characteristics associated with
premenopausal latent class membership. A partial proportional odds regression model was used to assess the
association between latent class membership and self-reported health status.
Results: We identified six latent classes that ranged from highly symptomatic (LC1) across most measured
symptoms, to moderately symptomatic across most measured symptoms (LC2), to moderately symptomatic for
a subset of symptoms (vasomotor symptoms, pain, fatigue, sleep disturbances and physical health symptoms)
(LC3 and LC5) with one class (LC3) including interference in life activities because of physical health symptoms,
to numerous milder symptoms, dominated by fatigue and psychological symptoms (LC4), to relatively asymptomatic
(LC6). In pre-menopause, 10% of women were classified in LC1, 16% in LC2, 14% in LC3 and LC4, 26% in LC5, and 20%
in LC6. Intensity of vasomotor and urogenital symptoms as well as sexual desire) differed minimally by latent class.
Classification into the two most symptomatic classes was strongly associated with financial strain, White race/ethnicity,
obesity and smoking status. Over time, women were most likely to remain within the same latent class as they
transitioned through menopause stages (range 39–76%), although some women worsened or improved. The
probability of moving between classes did not differ substantially by menopausal stage. Women in the highly
symptomatic classes more frequently rated their health as fair to poor compared to women in the least
symptomatic class.
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Conclusion: Clear patterns of symptom clustering were present early in midlife, tended to be stable over time,
and were strongly associated with self-perceived health. Notably, vasomotor symptoms tended to cluster with
sleep disturbances and fatigue, were present in each of the moderate to highly symptomatic classes, but were
not a defining characteristic of the symptom clusters. Clustering of midlife women by symptoms may suggest
common underlying mechanisms amenable to interventions. Given that one-quarter of midlife women were
highly or moderately symptomatic across all domains in the pre-menopause, addressing symptom burden in
early midlife is likely critical to ameliorating risk in the most vulnerable populations.
Keywords: Symptom clusters, Sleep, Pain, Fatigue, Vasomotor symptoms, Psychological symptoms, Menopause,
Aging, Latent transition analysis
Background
Studies of the menopausal transition have found that
women who experience hot flashes are at increased risk
of experiencing additional symptoms, such as anxiety,
depression or sleep, both concurrently and longitudinally
[1–4]. Woods [5] proposed that symptom clustering
may suggest common underlying mechanisms, and may
identify women at risk of adverse health outcomes or,
conversely, more likely to experience healthy aging. Stud-
ies of breast cancer patients have reported clustering of
depression, fatigue and sleep over time [6] and of fatigue,
pain and psychological symptoms [7] Studies of cardiovas-
cular disease suggest that symptom clustering differs by
age, with younger patients reporting more symptoms and
older patients reporting fewer but more diffuse symptoms
[8]. Despite interest in menopausal symptoms, relatively
few studies have evaluated symptom clustering among
midlife in women [5, 9–17].
Research conducted in nonclinical populations of mid-
life women find that women report different symptom
patterns, with clusters generally based on symptom in-
tensity and sometimes on whether or not vasomotor
symptoms cluster with other symptoms. Most previous
studies in midlife women include symptoms defined a
priori as being characteristic of menopause [9–17]. Cray
and colleagues [9–11] conducted principal component and
multilevel latent cluster analyses in the Seattle Women’s
Midlife Health Study (SWMHS) using data from a 3-day
symptom diary of 19 symptoms from six pre-defined symp-
tom groups (hot flashes, sleep, pain, mood, cognitive and
tension). One analysis suggested similar factor structures
across the stages of reproductive aging [11]. However, an-
other identified three latent classes: low symptom, low hot
flash/moderate symptoms and high hot flash/moderate
symptoms [10], that varied by menopausal stage. Women
were less likely to be in either of the two latent classes that
included hot flashes when they were premenopausal. In the
MsFLASH clinical trial, latent class analysis based on hot
flash, insomnia, sleep, depressed mood, anxiety and pain
symptoms identified 5 classes, 4 of which included hot
flashes [12]. Mishra and Dobson [13] conducted factor
analysis to identify symptom clusters of 17 general health
and menopausal symptoms using data from the Australian
Longitudinal Study of Women’s Health (ALSWH). They
identified four factors (somatic, urogynecological, vaso-
motor and physical). Longitudinal latent class analysis of
each of the four symptom groups suggested that women
clustered into patterns of mild, moderate, severe and very
severe symptoms that remained consistent over time and
across menopausal stages for all symptom groups except
the vasomotor symptom group, which differed by the tim-
ing of change in severity scores.
Additional analyses of SWMHS suggest that symptom
clustering was associated with both sex steroid hor-
mones [9, 14] and cortisol levels [9]. A high symptom
class was associated with decreased urinary cortisol
levels while the high hot flash/aches/wakening class was
associated with both higher urinary cortisol and lower
urinary estrone levels [9]. A more recent analysis of
symptom severity found that being in a class with severe
hot flashes was associated with higher urinary follicle-
stimulating hormone (FSH), lower urinary estrone and
higher epinephrine levels but not with cortisol levels
[14]. Greenblum and colleagues [15] using principal
components analysis in a clinical sample identified three
symptom clusters (psychological symptoms; weight gain
and urinary incontinence; and, vaginal dryness and sleep
disturbances), and reported that the vaginal dryness and
sleep disturbance cluster was most strongly associated
with self-reported quality of life.
Only a few studies have evaluated cross-cultural or
race/ethnic differences in symptom profiles. The four
country Decisions at Menopause Study (DAMES) found
that hot flashes grouped with other symptoms differentially
across countries [16]. Im and colleagues [17] reported race/
ethnic differences in reporting of the number and severity
of physical symptoms but only in the least symptomatic
cluster. The MS-Flash study reported that Black women
were more likely than White women to cluster in the severe
hot flash, insomnia and pain cluster [12].
In the multiethnic Study of Women’s Health Across
the Nation (SWAN), we have examined associations
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between pairs of symptoms [1–3] and a triad of symp-
toms (sleep disturbances, depressed mood and sexual
problems) [18] while Avis and colleagues [19] considered
evidence for a menopausal syndrome. In the present
paper, we used longitudinal data from SWAN to conduct
latent transition analysis to assess symptom clustering as
women transition through the menopause. Unlike most
prior studies, which defined symptom groups a priori, we
used a more agnostic, data-driven approach utilizing infor-
mation on all reported symptoms to construct latent clas-
ses of symptoms and estimate how women move between
these classes over time. Like Mishra and Dobson [13], our
aim is to understand the broader symptom experience of
midlife women and whether symptom clustering differs by
menopausal status. We further assess whether demo-
graphic characteristics, including race/ethnicity, body size
or smoking status were associated with specific symptom
clustering and evaluate the association between symptom
clustering and women’s self-reported health status.
Methods
This paper uses data from the longitudinal cohort study,
the Study of Women’s Health Across the Nation, details
of which have been described elsewhere [20]. In brief,
eligible women were identified through a cross-sectional
screening survey at seven clinical sites and enrolled in
the cohort study. Eligibility for the cohort study included
residence in the geographic area of the clinical site, being
age 42–52 years old, self-identification as White (at all
sites) or as Black (at the southeastern Michigan, Boston,
Chicago or Pittsburgh sites), Chinese (at the Northern
California site), Japanese (at the Southern California site)
and Hispanic (at the New Jersey site), the ability to speak
English, Cantonese, Japanese or Spanish and ability to give
verbal consent. In addition, women had to have an intact
uterus, at least one menstrual period and not have used
reproductive hormones in the past 3 months, and could
not be pregnant or lactating at the time of enrollment.
The study protocol was approved by the Institutional Re-
view Boards at each study site. A total of 3302 women
were enrolled in 1996/1997 and followed approximately
annually thereafter with 12 clinic visits completed by
2012, at which time the study remained in contact with
over 80% of surviving participants. All participants pro-
vided written, informed consent at each visit.
Each visit included interviewer-administered and self-
administered questionnaires on a broad range of topics,
including menstrual characteristics, socio-demographic
characteristics, lifestyle and physical, psychological, and
menopausal symptoms. Physical assessments included
measurement of height and weight.
As the set of questions asked varied by visit, we sought
to maximize the number of questions related to women’s
symptom profile while ensuring measurement consistency
across multiple visits. Thus this analysis includes data de-
rived from 58 questions included at the baseline visit, as
well as follow-up visits 1, 2, 3, 6, 8, 10 and 12. A woman’s
first observed visit in each stage of reproductive aging
(premenopausal, early-perimenopause, late-perimenopause
and post-menopause) was selected for inclusion in this
analysis. Given timing of the visits, women were not al-
ways observed at all stages. Data from an individual
visit were excluded when information on more than 10
of the included symptoms was missing, after a hysterec-
tomy or bi-lateral oophorectomy, or when menopausal
stage could not be classified because of HT use. Based
on these exclusions 13 women had no eligible observa-
tions, leaving 3289 women eligible for this analysis.
Menopausal stage
Menopausal stage was defined based on women’s self-
reported menstrual characteristics at each visit. Women
were classified as premenopausal if they had had a men-
strual period in the previous 3 months and reported no
change in menstrual regularity in the past 12 months; as
early peri-menopausal if they reported decreased regu-
larity in their menses in the past 12 months and had had
a menstrual period in the previous 3 months; as late
peri-menopausal if they had had no menses in the past
3–11 months; and, as postmenopausal if they had had
no menses for the past 12 or more months. Surgical
menopause was defined by report of either hysterectomy
or bilateral oophorectomy. Women were censored at the
time of surgical menopause (n = 237). At enrollment
women were either pre- or early peri-menopausal. Of
the 3289 women included in the analysis, 1761 were ob-
served at least once in the premenopausal stage, 2777 in
the early peri-menopausal stage, 927 in the late peri-
menopausal stage, and 2222 in the early post-menopause.
Symptoms
A total of 58 questions ascertained information on a
broad range of symptoms. Although a number of these
questions are items from existing scales intended to
measure specific concepts (e.g., items from the CESD
scale designed to measure depressive symptoms), this
data-driven approach considers each item independently.
This approach recognizes that women may differentially
endorse specific questions in a scale and that examining
the broader pattern of responses across large question
sets may yield new insights. The questions included here
were drawn from the SF-36 domains of role-physical,
bodily pain, role-emotional, vitality and social functioning
[21], the Center for Epidemiologic Studies Depression Scale
(CES-D) [22, 23], the 4-item Cohen’s Perceived Stress Scale
[24] as well as a 14-item list of general symptoms assessed
in SWAN and other studies of the menopausal transition
including vasomotor symptoms, mood symptoms, somatic
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symptoms and vaginal dryness [25–27]. For the latter,
women were asked how often within the past 2 weeks
(ranging from not at all to daily) they experienced each
symptom. Additional questions included items related
to self-reported sleep quality (trouble falling asleep and
staying asleep, waking early and perceived sleep quality)
[28, 29], as well as questions on involuntary urine loss
[30] and sexual desire [31].
Self-Reported Health was assessed by the question
“Would you say your health in general is excellent, very
good, good, fair or poor?” [21].
Covariates
Race/ethnicity was self-defined and categorized as Black,
Chinese, Japanese, Hispanic or White. Information on
highest level of education attained (high school gradu-
ate/GED or less than high school versus at least some
college), economic strain and smoking status (current,
past, never) was obtained at baseline. Economic strain
was assessed with the question “how hard is it to pay for
basics (very hard, somewhat hard or not hard)?” Height
and weight were measured without shoes, and in light
indoor clothing. BMI, calculated as weight in kilograms
divided by height in meters squared, was categorized as
underweight (<18.5 kg/m2), normal weight (18.5–24.9 kg/
m2), overweight (25.0–29.9 kg/m2), or obese (≥30.0 kg/m2).
Statistical analysis
Latent class analysis (LCA) [32] is a data reduction
method for categorical variables akin to factor analysis
for continuous variables. LCA estimates a probability pijk
of response to the kth category of the jth symptom for
the ith latent class. For example, based on our analyses,
the appetite symptom “I did not feel like eating; my appe-
tite was poor” is described by 44.4% of women in latent
class 1 (most symptomatic) as occurring “rarely or none of
the time” (=1), 26.6% as “some or a little of the time” (=2),
17.5% as “occasionally or a moderate amount of the time”
(=3), and 11.6% as “most or all of the time” (=4). In con-
trast, this symptom is described by 84.5% of women in la-
tent class 6 (minimally symptomatic) as occurring “rarely
or none of the time”, 11.7% as “some or a little of the
time”, 2.9% as “occasionally or a moderate amount of the
time”, and 0.8% as “most or all of the time”.
By assuming women belong to unobserved (latent)
groupings of reported symptoms, in which symptom
reports are assumed to be independent conditional on
latent class, a data-driven clustering of symptoms can
be determined. As an initial exploratory step we con-
ducted latent class analyses [32] cross-sectionally at each
menopausal stage to assess whether latent classes differed
across the menopausal transition. Analyses were con-
ducted first with all women and then with only those
women observed in all of the four menopausal stages to
evaluate whether the latent class structure was sensitive to
lost-to-follow up. These exploratory analyses indicated
that latent classes remained consistent over time and
across menopausal stage when a fixed set of symptoms
were included (data not shown).
Latent Transition analysis (LTA) extends LCA to a
longitudinal data setting [33, 34]. We used LTA to deter-
mine how symptoms cluster and to estimate how women
transition between the identified clusters across meno-
pausal stages (SAS PROC LTA) [33]. At each menopausal
stage (pre-menopause, early peri-menopause, late peri-
menopause and post-menopause) women are assumed to
belong to one of C unobserved (“latent”) classes. Condi-
tional on this latent class, each symptom is assumed to
have a specific distribution, and again conditional on this
latent class, all symptoms are assumed to be mutually
independent. Along with clustering of symptoms into
classes, LTA estimates a C x C transition matrix between
latent classes for each time point. Based on the explora-
tory analysis above and to assist in interpretation, latent
classes were kept constant across the time points.
The Bayesian Information Criterion (BIC) (which penal-
izes models with large numbers of latent classes to avoid
overfitting), along with scientific judgement, was used to
select the number of classes. Finally, since PROC LTA
does not use multiple start points to ensure convergence
of the LTA model, we introduced multiple start-points to
ensure consistent estimation of the global maximum
likelihood.
To summarize composition of latent classes (i.e., the
distribution of symptomatology across the latent classes),
we estimated average intensity of each symptom within
each class. Since symptoms were measured on different
scales (e.g. a few were dichotomous responses while
others might have as many as six response levels), we
standardized all symptom responses to a [0,1] scale, with
0 the most favorable category listed, and 1 being the
worst. This symptom intensity for a given class was con-






, where i indexes the latent
class, j the symptom question and k the category associated
with the symptom question (where response options were
consistently (re) ordered to run from “best” to “worst”).
Thus 0 ≤ Pij ≤ 1, with low intensity values corresponding to
latent classes in which women rarely reported problems
with that symptom and high intensity values (near 1) corre-
sponding to latent classes in which women often reported
problems with that symptom. For example, using the appe-
tite symptom and response probabilities for latent classes 1
and 6 presented above, the intensity is P1,APPETITE =
100 × (.444 × 0/3+.266 × 1/3+.175 × 2/3+.116 × 3/3) = 32.1
for latent class 1 and P6,APPETITE = 100 × (.845 × 0/3+.117 ×
1/3+.029 × 2/3+.008 × 3/3) = 6.6 for latent class 6. These in-
tensity measures are then summarized into a “heat map”
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corresponding to the measures of Pij to help interpret the
symptom intensity distribution results of the latent classes
produced by LTA. No a priori grouping of symptoms into
specific domains was assumed. In order to enhance inter-
pretation of the symptom distributions in each cluster, we
ordered the symptoms in the heat map by intensity level
across latent classes and grouped symptoms post hoc con-
ceptually (e.g. sleep disturbance, pain, psychological).
Joint multinomial logistic regression was used to com-
pute the odds of belonging to a given initial latent class
relative to a reference initial latent class as a function of
baseline covariates: age, obesity status, race/ethnicity,
smoking status (current, past or never smoker), financial
strain (very hard to pay for basics, hard to pay for basics,
not hard to pay for basics), and education (high school
graduate or less versus some college or more). A bootstrap
was used to compute empirical confidence intervals for
the final multivariable multinomial logistic regression on
baseline latent classes.
In order to determine whether the latent classes were
related to self-reported health (categorized as excellent,
very good, good and fair or poor) at each time point, a
four-level partial proportional odds regression model
was fit using the estimated symptom latent class at each
menopausal stage and menopausal status as predictors,
adjusted for age, obesity status, race/ethnicity, smoking
status, financial strain and education. This model was fit
using SAS PROC NLMIXED with a subject-level ran-
dom intercept to account for within-woman correlation
across the four time points. Variation in uncertainty of
the latent class assignment was addressed with entropy
based design weights [34].
Results
Women had a mean age of 45.7 years at baseline and a
mean BMI of 27.2 kg/m2. The study population was
28.3% Black, 47.0% White, 7.6% Chinese, 8.5% Hispanic,
and 8.5% Japanese (Table 1). One-quarter of the women
had a high school education or less and about one-third
reported they found it somewhat or very hard to pay for
basics. Less than half had ever smoked. At baseline, the
majority of women reported they had very good or ex-
cellent health, but 13.2% rated themselves as having fair
or poor health.
Latent classes
The LTA identified 6 distinct latent classes. These clas-
ses were ordered based on the number and intensity of
symptoms from 1 (most symptoms present and highest
intensity) to 6 (least symptoms present and least inten-
sity). Figure 1 provides the heat map showing symptom
intensity of each symptom within each latent class.
(Additional file 1 provides the full question item that
corresponds with the shorter symptom labels provided
in the heat map.) Latent Class 1 (LC1) is highly symp-
tomatic with high intensity ratings for most measured
symptoms. Latent Class 2 (LC2) is similar to LC1, but
with moderate intensity rating for most measured symp-
toms. Latent Classes 3–5 each include fewer moderate
to high intensity symptoms than LC1 or LC2. Latent
Class 3 (LC3) includes moderate intensity vasomotor,
pain, fatigue, sleep and physical health symptoms suffi-
cient to interfere in life activities, but fewer and lower
intensity psychological symptoms. Like LC1 and LC2,
Latent Class 4 (LC4) includes numerous symptoms but
Table 1 Baseline demographics of 3289 women in the analytic
sample, Study of Women’s Health Across the Nation (SWAN)
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of milder intensity, dominated by fatigue and psycho-
logical symptoms. Latent Class 5 (LC5) is similar to LC3
but does not include the physical health interference
items. Latent Class 6 (LC6) is relatively asymptomatic
with only a few, mild symptoms mostly related to fa-
tigue. Notably, vasomotor symptoms tended to cluster
with sleep disturbances and fatigue and were present in
each of the moderate to highly symptomatic clusters
(LC1,2,3 and 5). This triad represents the most intense
symptoms only in LC5. Intensity of low sexual desire
and urogenital symptoms differed little across classes.
Probability of transition from latent class to latent class
across reproductive stage
In the pre-menopause, fully 26% of women were classi-
fied as moderately to highly symptomatic: 10% in the
highly symptomatic LC1 and 16% in the moderately
symptomatic LC2. Another 40% were classified as
Fig. 1 Heat map of symptom intensity by six defined latent classes with darker blue indicating higher intensity symptoms, Study of Women’s
Health Across the Nation (SWAN)
Harlow et al. Women's Midlife Health  (2017) 3:2 Page 6 of 13
moderately symptomatic for a subset of measured symp-
toms: 14% in LC3 and 26% in LC5. Another 14% were
classified as mildly symptomatic (LC4) while 20% were
classified in relatively asymptomatic cluster (LC6).
Because transition probabilities did not differ signifi-
cantly across menopausal stages (X2 = 76.84 on 64 df,
p-value = 0.13), transition probabilities were set to be
constant over time. Table 2 provides the probability of
women in a given class transitioning to the same or a
different class from one menopausal stage to the next.
Although symptoms improved and/or worsened for
some women, most women remained in their same
class at each subsequent time-point.
Figure 2 illustrates how the LC transition probabilities
affect the movement of women from one class to an-
other and the resultant proportion of women in each la-
tent class at each stage of the menopausal transition.
The width of the lines represents the probability of
moving from class to class. Thus the wide vertical lines
illustrate that women were most likely to remain in their
same class as they transitioned through menopause. The
thinner diagonal lines represent the lower probability of
movement between classes, particularly more distant clas-
ses. By post-menopause, the probability of being in each
latent class was 8% for the most highly symptomatic LC1,
16%, 12%, 15% and 26% for latent classes 2–5, respectively
and 24% for the least symptomatic LC6. The biggest dif-
ferences by menopausal stage can be seen in LC4 and
LC5: 26% of premenopausal women were in class 4 com-
pared to 15% by the post-menopause whereas 14% of pre-
menopausal women were in LC5 compared to 26% by the
post-menopause.
Characteristics associated with latent class membership
Table 3 presents the fully adjusted model for the associ-
ation of baseline sociodemographic factors, obesity status
and smoking status with the probability of being in each
latent class compared to being in the least symptomatic
LC6 (referent) at the premenopausal visit. After adjusting
for all other covariates in the model, financial strain stands
out as the variable most strongly and consistently related
to symptoms. Having a somewhat or very hard time pay-
ing for basics was associated with over a five-fold and
seventeen-fold increased odds, respectively, of being in the
most symptomatic class (LC1) as well as with over a four-
fold increased odds of being in the moderate symptom
class (LC5) compared to women who did not report finan-
cial strain. Being obese was associated with a more than a
two-fold odds of being in the highly symptomatic class
(LC1) or the mildly symptomatic class (LC 5) : and with
an 80% increase in the odds of being in the moderately
symptomatic class (LC2) compared to non-obese women.
Black women were one-half to one-third as likely to be in
the more symptomatic clusters LC1 to LC3 than White
women with similar characteristics, while Japanese were
less likely to be in LC1 and Chinese women were less
likely to be in LC2 than White women. Current smokers
had a two and half fold increased odds and past smokers
had a 75% increased odds of being in LC1 compared to
never smokers. Older age at baseline was associated with
slightly reduced odds of being in the more highly symp-
tomatic LC1 and LC2, compared to younger women, al-
though the confidence interval for the former includes 1.0.
Level of education was not independently associated with
latent symptom classes.
Association between latent class membership and
self-reported health status
Table 4 presents the regression coefficients for the asso-
ciation of self-reported health with menopausal stage
and latent class membership adjusted for age, obesity,
education, difficulty paying for basics, current smoking
and race/ethnicity. (The distribution of self-reported
health by menopausal status and latent class is provided
in Additional file 2). Although, women in the late peri-
and post- menopause were somewhat more likely to re-
port being in fair to poor health compared to when
they were premenopausal, women in the high to mod-
erate symptomatic latent classes were much more likely
to rate their health as fair to poor than women in the
least symptomatic class. For example, based on the re-
gression coefficients presented in Table 4, the odds of
being in less than excellent health, less than very good
health and less than good health were 3.56, 2.94 and
1.60 times higher for postmenopausal compared to pre-
menopausal women, respectively. The comparable in-
creased odds were 7.48, 8.21 and 9.73 times higher for
women in LC1 compared to LC6. Figure 3 plots the
odds ratios for each level of self-reported health by la-
tent class to more clearly illustrate the magnitude of
the association between LC and perceived health.
Table 2 Latent class transition probabilities (latent classes
numbered from maximal symptoms (1) to least symptoms (6)),
Study of Women’s Health Across the Nation(SWAN)
Probability of transition to latent classt+1
Latent Classt 1 2 3 4 5 6
1 0.55 0.26 0.04 0.10 0.03 0.03
2 0.12 0.47 0.12 0.14 0.13 0.01
3 0.04 0.14 0.39 0.11 0.23 0.10
4 0.04 0.13 0.07 0.44 0.20 0.11
5 0.01 0.08 0.09 0.07 0.62 0.13
6 0.01 0.00 0.06 0.06 0.11 0.76
(the diagonal, in bold, is the proportion of women who remain in the same
latent class)
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Discussion
The evaluation of a broad range of physical and psycho-
logical symptom in a multi-ethnic cohort of midlife women
contextualizes symptoms thought to be associated with
menopause (e.g. hot flashes) within midlife women’s overall
symptom experience. We identified six latent symptom
classes that ranged from highly or moderately symptomatic
across all measured symptoms, to moderately symptomatic
for a subset of symptoms (vasomotor, pain, fatigue, sleep
and physical health), to mildly symptomatic predominately
associated with fatigue and psychological symptoms, to
minimally or asymptomatic. Notably, vasomotor symptoms
tended to cluster with sleep disturbances and fatigue, but
were the most intense symptoms within only one mildly
symptomatic latent class. Other symptoms often associated
with menopause – low sexual desire and urogenital symp-
toms – were also not unique to, or of differential intensity,
across the latent classes. This finding suggests that women
may perceive these symptoms differently from other symp-
tom domains, or that their underlying physiologic or social
correlates differ from the other symptoms measured here.
Although some women worsened or improved over time,
they tended to track within latent class and menopausal
stage did not influence the probability of movement
between latent classes. Notably, one-quarter of the
women were highly or moderately symptomatic in the
pre-menopause and latent class was strongly associated
with women’s self-perceived health.
These clustering patterns provide interesting insights
into the aging and disablement processes. Sleep and fa-
tigue symptoms, though mild, were present even in the
least symptomatic cluster. As clusters became more
symptomatic, sleep disturbance and fatigue symptoms
worsened and pain symptoms emerged, becoming more
prevalent and severe in the more symptomatic clusters.
Psychological symptoms were prominent in just three of
the six classes, but the two most highly symptomatic
classes were characterized by having multiple, high/
moderate intensity psychological symptoms.
The co-occurrence of sleep, fatigue and vasomotor
symptoms has been reported by other studies [9] while
SWAN has reported a triad of symptoms (sleep distur-
bances, depressed mood and sexual problems) associated
with lower household incomes, less education and fair to
poor self-rated health [18]. In the SWMHS, the high hot
flash/aches/wakening cluster was associated with low es-
trone [9] while higher FSH and lower estradiol levels
were associated with being in the severe hot flash cluster
Fig. 2 Proportion of women in each latent class (estimated probability presented in circles and area of circle proportional to the probability) by
menopausal status and transition probabilities across menopausal stage (shown by thickness and direction of lines), Study of Women’s Health
Across the Nation (SWAN)
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Table 4 Association of latent class and menopausal status with self-reported healtha (latent classes numbered from most symptomatic
(1) to least symptomatic (6)), Study of Women’s Health Across the Nation
Self-reported health Beta (95% CL)
Less than excellent vs. excellent Less than very good vs. very good or better Fair/poor vs. good or better
Menopausal status
Pre ref ref ref
Early peri 0.54 (0.32, .76) 0.34 (0.14,0.54) 0.12 (−0.15, 0.39)
Late peri 1.34 (1.01, 1.67) 0.89 (0.64, 1.14) 0.39 (0.04, 0.74)
Post 1.31 (1.07, 1.55) 1.08 (0.88, 1.28) 0.59 (0.32, 0.86)
Latent class
1 2.75 (2.20,3.30) 3.02 (2.67, 3.37) 3.58 (3.13, 4.03)
2 1.99 (1.66, 2.32) 2.05 (1.78, 2.32) 2.14 (1.73, 2.55)
3 1.80 (1.43, 2.17) 2.09 (1.80, 2.38) 2.43 (2.00, 2.86)
4 1.06 (0.79, 1.33) 1.06 (0.81, 1.31) 0.91 (0.46, 1.36)
5 1.14 (1.39, 2.05) 0.92 (0.67, 1.17) 0.78 (0.31, 1.25)
6 ref ref ref
aAdjusted for obesity, education, difficulty paying for basics, current smoking, race/ethnicity and age
Table 3 Socio-demographic and lifestyle factors associated with premenopausal latent class ((latent classes numbered from most
symptomatic (1) to less symptomatic (5), all compared to the least symptomatic (6, referent)), Study of Women’s Health Across the
Nation (SWAN)
Latent class (reference = LC6)
1 2 3 4 5
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Age 0.94 (0.89, 1.00)a 0.92 (0.87, 0.98) 1.04 (0.96, 1.13) 0.95 (0.88, 1.03) 1.00 (0.94, 1.06)
Body mass index
Obese 2.34 (1.46, 3.74) 1.80 (1.11, 2.94) 1.25 (0.53, 2.95) 1.05 (0.47, 2.35) 2.64 (1.11, 6.25)
Not obese ref ref ref ref ref
Race/ethnicity
Black 0.54 (0.30, 0.97) 0.42 (0.24, 0.76) 0.38 (0.16, 0.92) 0.59 (0.31, 1.16) 0.59 (0.32, 1.11)
White ref ref ref ref ref
Chinese 0.55 (0.18, 1.68) 0.43 (0.19, 0.96) 0.36 (0.10, 1.29) 1.20 (0.41, 3.52) 0.73 (0.34, 1.53)
Hispanic 1.16 (0.48, 2.81) 0.94 (0.37, 2.37) 0.26 (0.04, 1.82) 0.66 (0.26, 1.65) 1.55 (0.49, 4.94)
Japanese 0.21 (0.06, 0.70) 0.66 (0.28, 1.57) 0.37 (0.11, 12.80) 0.99 (0.32, 3.09) 0.58 (0.23, 1.42)
Smoking status
Past 1.75 (1.09, 2.80) 1.13 (0.66, 1.91) 1.57 (0.81, 3.05) 1.08 (0.66, 1.77) 0.95 (0.55, 1.65)
Current 2.53 (1.52, 4.22) 1.42 (0.89, 2.27) 0.79 (0.38, 1.64) 0.95 (0.50, 1.82) 1.07 (0.61, 1.89)
Never ref ref ref ref ref
How hard it is to pay for basics
Very 17.80 (8.50, 37.50) 4.85 (2.31, 10.20) 1.46 (0.40, 5.33) 3.63 (1.59, 8.27) 1.72 (0.58, 5.04)
Somewhat 5.75 (3.46, 9.58) 4.10 (2.66, 6.30) 2.01 (1.03, 3.92) 2.53 (1.38, 4.65) 2.01 (1.10, 3.70)
Not at all ref ref ref ref ref
Education
HS or less 1.54 (0.94, 2.51) 1.04 (0.63, 1.73) 0.56 (0.23, 1.35) 1.05 (0.61, 1.82) 0.77 (0.42, 1.42)
Some college ref ref ref ref ref
aSignificant Odds Ratios are bolded
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[14]. Future analyses of the SWAN data will assess the
association between the identified symptom clusters and
reproductive hormone levels.
Across previous studies, the number and content of
factors/latent classes varies dependent on the number of
women in the analytical sample, the number and types
of symptoms considered, and the methodology used to
identify clusters. For example, analyses from the SWMHS
[9–11, 14] were based on a 3-day symptom diary that
ascertained 47 symptoms, but the publications included
fewer and a varied number of symptoms (i.e., 22, 19 or
15 symptoms or 5 indicator symptoms) and different
subsets of the study population (n = 103 to 292 women).
Nonetheless high/moderate symptom and low symptom
profiles were evident in each analysis, with hot flashes
often emerging more clearly in the low symptomatology
clusters, as observed here.
The saliency of hot flashes in many studies may reflect
their identification a priori as a study focus [10] or because
the sample over-represented women who self-identified as
having troublesome hot flashes [12]. The ALSWH in-
cluded a broad range of symptoms in a population-based
sample of women [13], identified vasomotor symptoms as
one and uro-gynecological symptoms as another of four
factors. However, the ALSWH study included a list of just
17 symptoms. In the present analysis, the triad of vaso-
motor symptoms, sleep disturbance and fatigue stood out
uniquely only in an otherwise low symptomatic cluster
(LC5), but were present in 5 of the 6 classes. Unlike the
ALSWH, we found that intensity of low sexual desire and
urogenital symptoms differed little across latent classes.
We found that the number and symptom content of
the latent classes was consistent across menopausal
stage. Similar symptom factor structures across stages
of reproductive aging have also been reported in the
SWMHS [11]. In the ALSWH, severity of women’s
scores tended to remain stable over a 14-year period [13].
As might be expected, current and former smokers
were more likely to be classified in the highly symptom-
atic cluster as were obese women. However, experien-
cing financial strain was the risk factor most strongly
associated with being in the highly symptomatic clusters.
Financial strain has been shown to be a major correlate
of disability in SWAN [35] and other studies [36, 37]. In-
dividuals with substantial financial limitations may be a
particularly vulnerable group lacking health care access
and related resources.
Only a few studies have evaluated cross-cultural or
race/ethnic differences in symptom profiles. In the DAMES
study [16], hot flashes did not cluster with other symptoms
in the United States or Lebanon, but clustered with vaginal
dryness and sexual symptoms in Spain and with general
symptoms in Morocco. A multi-ethnic internet-based
survey [17], observed differences by race/ethnicity only
in the least symptomatic cluster: Black and White women
reported more and greater severity of symptoms com-
pared to Hispanic and Asian women. In contrast, the
MS-Flash study reported that Black women were more
likely than White women to cluster in the severe hot
flash, insomnia and pain cluster [12]. In the present
multi-ethnic study, after controlling for other covariates
including financial strain, Black women but also Japanese
and Chinese women were less likely to be classified in the
most symptomatic latent classes.
Notably, one quarter of premenopausal women were
highly or moderately symptomatic and experiencing
Fig. 3 Adjusted Odds Ratios for different levels of self-reported health by latent class, Study of Women’s Health Across the Nation (SWAN)
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numerous physical and psychological symptoms. Thus
prior to beginning the menopausal transition a substan-
tial proportion of women were highly symptomatic.
Consistent with other studies examining the impact of
high symptomatology on quality of life [7, 10], women
in the high symptomatic cluster were most likely to
perceive themselves in fair to poor health. The SWAN
study population excluded women who experienced
menopause earlier than their same age peers and women
who were surgically menopausal. Given that earlier meno-
pause and surgical menopause is associated with poorer
health and mortality [38–41], participants were likely
healthier than the general population of midlife women.
Thus, this analysis may underestimate the proportion of
women who are highly symptomatic as they enter the
midlife, as further evidenced by the fact that older women
at baseline tended to be in the less symptomatic latent
classes. Further evaluation of symptom burden in the mid-
life may provide increased understanding of risk factors
for the development of multiple morbidities and disability
in later life. In the ALSWH, among women aged 76–81
years, multi-morbidity in the musculoskeletal/somatic,
neurological/mental health and cardiovascular domains
were each associated with poorer function as measured by
Activities of Daily Living and the Instrumental Activities
of Daily Living Scales [42].
This study has some limitations. As noted above, the
SWAN cohort was left truncated and likely excluded
women in poorer health [38]. Similarly, women who
were lost to follow-up may have been in poorer health.
Thus the burden of high symptomatology in midlife
women may be underestimated. Although some bias
may exist, retention in the SWAN cohort is fairly high
(81% of the living participants at visit 12). Results from
the latent class analyses were similar when we used
complete cases and all cases, and the findings were ro-
bust across visits and menopausal status. Finally, as-
sessment of urogenital symptoms as well as sexual desire
was limited to only one question each and may not have
fully ascertained women’s symptom experience in these
domains.
The study has several strengths. This analysis includes
data from a community based and multiethnic cohort of
over 2900 midlife women followed longitudinally, enabling
us to evaluate the stability of latent classes and transition
probabilities over time and across the stages of the
menopausal transition in a large sample of women and
to evaluate potential race/ethnic differences. As identifica-
tion of latent class structure is dependent on the symptom
domains included in the analysis and, to a lesser extent,
on the number of symptoms allocated to a given domain,
our inclusion of 58 symptom responses from a broad
range of symptom domains, without a priori selection to
highlight purported menopausal symptoms, enabled us to
characterize women’s menopausal experience within their
broader life and health experience.
Conclusions
This paper illustrates that midlife women experience
substantially different symptom burdens, that a large
fraction of women report a significant symptom burden
prior to the onset of the menopausal transition, that
high and intense symptomatology across physical and
psychological domains is strongly associated with financial
strain, and that a high symptom burden influences
women’s perception of being in fair or poor health. Vaso-
motor symptoms cluster with sleep disturbances and fa-
tigue, but are of unique salience to women’s symptom
burden only in a relatively small subset of women. Given
that one-quarter of midlife women were already highly or
moderately symptomatic in the pre-menopause, ensuring
access to chronic disease preventive strategies in the
early midlife is likely critical to ameliorating risk in the
most vulnerable populations. Development of rigorous,
evidence-based protocols for health and functional eval-
uations, inclusive of physical and mental health assess-
ments as well as prevention and intervention guidance for
women as they reach the midlife is likely warranted.
Future studies should evaluate whether women with
high symptomatology as they enter the midlife are at
risk of premature mortality or earlier onset of disability,
and whether low symptomatology at the onset of this
life stage is a marker of healthy aging.
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